Tevogen Bio Holdings Inc.TVGNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank24
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P24
Within normal range
vs 2Y Ago
-0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-14.42%
Q2 20253.58%
Q1 2025-8.54%
Q4 202419.90%
Q3 2024-27.57%
Q2 2024-37.84%
Q1 2024-9.48%
Q4 2023-9.80%
Q3 202318.83%
Q2 2023-1.85%
Q1 202320.45%
Q4 2022-36.35%
Q3 2022-4272.99%
Q2 202259.39%
Q1 202284.16%
Q4 20210.00%
Q3 20210.00%
Q2 20210.00%